Ichor Holdings, Ltd. (ICHR)

Intra-Cellular Therapies Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 5, 2025	Dec 27, 2024	Dec 29, 2023	Dec 30, 2022	Dec 31, 2021	Dec 25, 2020
Market Capitalization	481	1,058	988	772	1,308	831
Market Cap Growth	-51.22%	7.10%	27.91%	-40.93%	57.35%	9.15%
Enterprise Value	557	1,108	1,231	1,055	1,254	966
Last Close Price	20.14	31.37	33.63	26.82	46.03	30.46
PE Ratio	-	-	-	10.61	18.45	24.97
Forward PE	19.66	26.46	57.49	10.08	11.54	10.92
PS Ratio	0.76	1.25	1.22	0.60	1.19	0.91
PB Ratio	0.98	1.52	1.75	1.32	2.61	2.02
P/TBV Ratio	1.54	3.49	6.03	4.49	20.66	4.22
P/FCF Ratio	-	103.30	23.45	382.42	-	29.73
P/OCF Ratio	28.29	37.96	17.14	24.56	85.63	21.72
PEG Ratio	0.40	0.90	0.90	0.90	0.90	0.32
EV/Sales Ratio	0.60	1.31	1.52	0.82	1.14	1.06
EV/EBITDA Ratio	21.97	48.59	49.67	8.72	11.72	14.68
EV/EBIT Ratio	-	-	-	12.29	15.48	23.24
EV/FCF Ratio	-	108.20	29.20	522.11	-	34.54
Debt / Equity Ratio	0.24	0.25	0.51	0.58	0.65	0.51
Debt / EBITDA Ratio	4.65	5.31	8.32	2.64	2.86	2.96
Debt / FCF Ratio	-	17.01	6.80	169.18	-	7.54
Asset Turnover	0.96	0.88	0.80	1.22	1.22	1.36
Inventory Turnover	3.32	3.00	2.67	4.11	4.96	6.03
Quick Ratio	1.27	1.44	1.48	1.34	1.05	2.18
Current Ratio	3.22	3.34	4.06	3.09	2.22	3.06
Return on Equity (ROE)	-2.98%	-3.30%	-7.46%	13.38%	15.54%	10.51%
Return on Assets (ROA)	-0.29%	-0.43%	-0.54%	5.10%	5.64%	3.87%
Return on Capital (ROIC)	-0.33%	-0.49%	-0.61%	6.12%	7.00%	5.01%
Return on Capital Employed (ROCE)	-	-	-	9.40%	10.00%	6.80%
Earnings Yield	-4.29%	-1.97%	-4.35%	9.43%	5.42%	4.00%
FCF Yield	-3.94%	0.97%	4.26%	0.26%	-0.43%	3.36%
Buyback Yield / Dilution	-10.96%	-12.19%	-0.82%	0.06%	-23.53%	-3.04%

Updated Aug 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q